Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.920
+0.060 (2.10%)
At close: Sep 11, 2026, 4:00 PM EDT
2.930
+0.010 (0.34%)
After-hours: Sep 11, 2026, 6:21 PM EDT
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $211.17 million as of September 11, 2026. Its market cap has increased by 158.23% in one year.
Market Cap
211.17M
Enterprise Value
132.62M
1-Year Change
158.23%
Ranking
Category
Stock Price
$2.92
ChartMarket Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $211.17M, a decrease of -65.85%. That is a compound annual growth rate of -18.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 211.17M | 65.22% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 215.13M |
| Satellos Bioscience | 212.73M |
| Nkarta | 208.43M |
| Coherus Oncology | 203.94M |
| Armata Pharmaceuticals | 201.15M |
| Voyager Therapeutics | 200.26M |
| Precision BioSciences | 200.11M |
| Oramed Pharmaceuticals | 198.84M |